RVL Pharmaceuticals 

$0.000010
15
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0005
Day Low
0.000001
52W High
0.0005
52W Low
0.000001
Volume
600
Avg. Volume
0
Mkt Cap
993.92
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q4 0
Q1 2024
Q2 2024
Q3 2024
-0.06
-0.05
-0.03
-0.02
Expected EPS
-0.04
Actual EPS
N/A

Financials

-103.96%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
49.72MRevenue
-51.69MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

RVL Pharmaceuticals plc operates as a specialized drug company, dedicated to innovating and marketing pharmaceutical solutions for patient groups with unmet needs in the ophthalmic and medical aesthetics domains. The firm's activities extend across the United States, Argentina, and Hungary. Its principal commercial offering is Upneeq (RVL-1201), an ophthalmic solution containing oxymetazoline hydrochloride, specifically formulated to address acquired blepharoptosis, or drooping eyelids, in adults. The company, formerly known as Osmotica Pharmaceuticals plc, officially rebranded to RVL Pharmaceuticals plc in January 2022. Its corporate headquarters are situated in Bridgewater, New Jersey.
Show more...
CEO
Brian A. Markison
Employees
125
Country
Ireland
ISIN
IE00BF2HDL56
WKN
000A2N6WE

Listings

0 Comments

Share your thoughts

FAQ

What is RVL Pharmaceuticals stock price today?
The current price of RVLPQ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch RVL Pharmaceuticals stock price performance more closely on the chart.
What is RVL Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange RVL Pharmaceuticals stocks are traded under the ticker RVLPQ.
Is RVL Pharmaceuticals stock price growing?
RVLPQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year RVL Pharmaceuticals has showed a +0% increase.
What is RVL Pharmaceuticals market cap?
Today RVL Pharmaceuticals has the market capitalization of 993.92
What is RVL Pharmaceuticals revenue for the last year?
RVL Pharmaceuticals revenue for the last year amounts to 49.72M USD.
What is RVL Pharmaceuticals net income for the last year?
RVLPQ net income for the last year is -51.69M USD.
How many employees does RVL Pharmaceuticals have?
As of September 05, 2026, the company has 125 employees.
In which sector is RVL Pharmaceuticals located?
RVL Pharmaceuticals operates in the Health & Wellness sector.
When did RVL Pharmaceuticals complete a stock split?
RVL Pharmaceuticals has not had any recent stock splits.
Where is RVL Pharmaceuticals headquartered?
RVL Pharmaceuticals is headquartered in Bridgewater, Ireland.